- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03437317
Emotional Perceptual Training as a Treatment for Social Anxiety: Behavioral and Neural Evidence. (PTL)
February 12, 2018 updated by: Wen Li, Florida State University
The Perceptual Training Study is a series of studies performed with the purpose of identifying a potential avenue for treatment of mood disorders, particularly anxiety-based mood disorders.
The underlying theme is that neural representations may be threat-oriented, and may also be generalized to non-threatening cues by means of similarity to threatening representations.
These may result in anxiety symptoms from innocuous cues.
The idea behind the perceptual training is to create a divorce between the threat representations and cues which should be considered non-threatening, enhancing perceptual acuity and potentially reducing anxiety symptoms.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
154
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 35 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Right-handed
- Normal or corrected-to-normal vision
Exclusion Criteria:
- History of a diagnosed neurological or Diagnostic and Statistical Manual of Mental Disorders - IV Axis I disorder
- Currently taking prescribed psychoactive drugs, including anti-depressants or anxiolytics.
- Having electrically, magnetically, or mechanically activated implants (e.g. cardiac pacemakers), due to incompatibility with MRI and MEG systems.
- Pregnancy or suspected pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Active - MEG
Participants completed 1 session of 8 Perceptual Retraining blocks following an instructional presentation.
|
Participants viewed faces varying in their expression of anger and were asked to identify if the face was angry or neutral via button press.
Participants were provided with feedback if their categorization of the face as neutral or angry was correct.
Each participant was assigned 4 levels of angry faces based on their decision point of anger detection in faces.
Faces were selected based on the closest existing anger morph to the category boundary; for example, a decision point of 40% anger was closest to the 38% anger face, and so the faces used would have been 17%, 31%, 45%, and 59% anger.
For this example, responses of "neutral" to the 31% angry face would be marked as correct, whereas a similar response to the 45% angry face would be incorrect, as it was above their decision point.
|
Sham Comparator: Control - MEG
Participants completed 1 session of 8 blocks of Gender Discrimination Task.
|
Participants viewed faces varying in their expression of anger and were asked to identify if the face was male or female via button press.
|
Experimental: Active - 3 Behavior/EEG
Participants completed 3 sessions of Perceptual Retraining following an instructional presentation.
The first session included 6 blocks of perceptual training, and the second session included 12 blocks of perceptual training.
No perceptual training was performed in session 3. Sessions were spaced approximately 7 days apart, with a minimum of 3 days and a maximum of 14 days apart.
|
Participants viewed faces varying in their expression of anger and were asked to identify if the face was angry or neutral via button press.
Participants were provided with feedback if their categorization of the face as neutral or angry was correct.
Each participant was assigned 4 levels of angry faces based on their decision point of anger detection in faces.
Faces were selected based on the closest existing anger morph to the category boundary; for example, a decision point of 40% anger was closest to the 38% anger face, and so the faces used would have been 17%, 31%, 45%, and 59% anger.
For this example, responses of "neutral" to the 31% angry face would be marked as correct, whereas a similar response to the 45% angry face would be incorrect, as it was above their decision point.
|
Experimental: Active - 1 Behavior/MEG
Participants completed 1 session of 6 Perceptual Retraining blocks following an instructional presentation.
|
Participants viewed faces varying in their expression of anger and were asked to identify if the face was angry or neutral via button press.
Participants were provided with feedback if their categorization of the face as neutral or angry was correct.
Each participant was assigned 4 levels of angry faces based on their decision point of anger detection in faces.
Faces were selected based on the closest existing anger morph to the category boundary; for example, a decision point of 40% anger was closest to the 38% anger face, and so the faces used would have been 17%, 31%, 45%, and 59% anger.
For this example, responses of "neutral" to the 31% angry face would be marked as correct, whereas a similar response to the 45% angry face would be incorrect, as it was above their decision point.
|
Sham Comparator: Control - 3 Behavior/MEG
Participants completed 3 sessions of a Gender Discrimination Task.
The first session included 6 blocks of gender discrimination task, and the second session included 12 blocks of the gender discrimination task.
No gender discrimination task was performed in session 3. Sessions were spaced approximately 7 days apart, with a minimum of 3 days and a maximum of 14 days apart.
|
Participants viewed faces varying in their expression of anger and were asked to identify if the face was male or female via button press.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Behavioral Evidence for Categorical Perception Changes
Time Frame: Baseline to Study Completion (14 to 28 Days)
|
Participants will be asked to respond if they detected anger in faces varying in their levels of anger expression.
This task is used to determine a perceptual bias for threat/anger in faces that is related to increases in social anxiety symptoms, and assess for improvements in the categorization of angry vs. neutral faces.
that align with modulations of neural responses (MEG and EEG evidence) indexing perceptual processing of the faces following perceptual retraining.
|
Baseline to Study Completion (14 to 28 Days)
|
Neural Evidence for Categorical Perception Changes
Time Frame: Baseline to Study Completion (14 to 28 Days)
|
Neural activity will be recorded using EEG and MEG to measure neural processes underpinning categorical perception of anger in faces.
Changes in this neural perceptual index will be assessed following perceptual retraining to provide a neural mechanism underpinning behavioral improvements in perceptual categorization and subsequent reductions in anxiety.
|
Baseline to Study Completion (14 to 28 Days)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Social Anxiety Symptoms - Social Phobia Scale
Time Frame: Baseline to Study Completion (14 to 28 Days)
|
Change in social anxiety symptomatology through perceptual retraining
|
Baseline to Study Completion (14 to 28 Days)
|
Social Anxiety Symptoms - Liebowitz Social Anxiety Scale
Time Frame: Baseline to Study Completion (14 to 28 Days)
|
Change in social anxiety symptomatology through perceptual retraining
|
Baseline to Study Completion (14 to 28 Days)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2014
Primary Completion (Actual)
December 15, 2016
Study Completion (Actual)
December 15, 2016
Study Registration Dates
First Submitted
February 6, 2018
First Submitted That Met QC Criteria
February 12, 2018
First Posted (Actual)
February 19, 2018
Study Record Updates
Last Update Posted (Actual)
February 19, 2018
Last Update Submitted That Met QC Criteria
February 12, 2018
Last Verified
February 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PTL-2017.21521
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Social Anxiety Disorder
-
Aya Technologies LimitedCompletedSocial Anxiety | Social Anxiety Disorder | Social Anxiety Disorder (Social Phobia)United Kingdom
-
Tel Aviv UniversityCompletedSocial Anxiety | Social Anxiety Disorder | Social Anxiety Disorder (Social Phobia)Israel
-
Aya Technologies LimitedCompletedSocial Anxiety | Social Anxiety Disorder | Social Anxiety Disorder (Social Phobia)United Kingdom
-
University of BernUniversity of LuebeckActive, not recruitingSocial Anxiety Disorder (Social Phobia)Switzerland
-
Daniel LiebermanTerminatedAnxiety | Anxiety Disorder SocialUnited States
-
Weill Medical College of Cornell UniversityBrain & Behavior Research FoundationTerminatedSocial Anxiety | Social Anxiety Disorder | Social Anxiety Disorder of ChildhoodUnited States
-
Tufts UniversityCompletedSocial Anxiety | Social Anxiety Disorder | Social Anxiety Disorder of ChildhoodUnited States
-
Sumitomo Pharma America, Inc.BehaVR LLCCompletedSocial Anxiety Disorder (SAD)United States
-
Emory UniversityBristol-Myers SquibbCompleted
-
Florida International UniversityYale UniversityRecruitingSocial Anxiety Disorder of ChildhoodUnited States
Clinical Trials on Perceptual Retraining
-
Yocheved LauferClalit Health Services, Haifa and West GalileeCompletedStroke | Sensory DeficitsIsrael
-
Florida State UniversityUnited States Department of Defense; Southeast Louisiana Veterans Health Care...Completed
-
University of Texas at AustinCompletedHealthy Subjects | Neuropsychiatric DisordersUnited States
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityNot yet recruiting
-
Ohio State UniversityNational Institute on Aging (NIA)Not yet recruitingHealthy AgingUnited States
-
Northwestern UniversityCompletedDiagnostic Self Evaluation | Lesion; PigmentUnited States
-
University of DelawareNortheastern UniversityRecruitingDevelopmental Language Disorder | Adults Without Language DisorderUnited States
-
Asan Medical CenterCompletedStroke | Visual Field DefectKorea, Republic of
-
Eunice Kennedy Shriver National Institute of Child...Active, not recruitingObesity | Overweight | Healthy Volunteers | Binge EatingUnited States
-
Chang Gung Memorial HospitalUnknownSurgery | Mandibular Prognathism | Injury of Trigeminal NerveTaiwan